BD Posts 4 Percent Increase in Q2 Revenues | GenomeWeb

NEW YORK (GenomeWeb) – Becton Dickinson today reported that its second quarter revenues increased around 4 percent year over year driven by growth in its BD Medical and BD Biosciences business segments.

BD reported total revenues of $2.07 billion for the three months ended March 31, up from $2.00 billion for the second quarter of 2013. It fell short of the average analyst estimate of $2.09 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."